title: Reversibility and heritability of liver fibrosis: Implications for research and therapy.
abstract: Liver fibrosis continues to be a major health problem worldwide due to lack of effective therapy. If the etiology cannot be eliminated, liver fibrosis progresses to cirrhosis and eventually to liver failure or malignancy; both are associated with a fatal outcome. Liver transplantation, the only curative therapy, is still mostly unavailable. Liver fibrosis was shown to be a reversible process; however, complete reversibility remains debatable. Recently, the molecular markers of liver fibrosis were shown to be transmitted across generations. Epigenetic mechanisms including DNA methylation, histone posttranslational modifications and noncoding RNA have emerged as major determinants of gene expression during liver fibrogenesis and carcinogenesis. Furthermore, epigenetic mechanisms have been shown to be transmitted through mitosis and meiosis to daughter cells and subsequent generations. However, the exact epigenetic regulation of complete liver fibrosis resolution and inheritance has not been fully elucidated. This communication will highlight the recent advances in the search for delineating the mechanisms governing resolution of liver fibrosis and the potential for multigenerational and transgenerational transmission of fibrosis markers. The fact that epigenetic changes, unlike genetic mutations, are reversible and can be modulated pharmacologically underscores the unique opportunity to develop effective therapy to completely reverse liver fibrosis, to prevent the development of malignancy and to regulate heritability of fibrosis phenotype.
authors.affiliation: Hussein M Atta, Department of Surgery, Faculty of Medicine, Minia University, El-Minia 61519, Egypt.
authors.forename: Hussein M
authors.initials: HM
authors.lastname: Atta
mesh_terms: D000818:Animals; D035843:Biomedical Research; D019175:DNA Methylation; D044127:Epigenesis, Genetic; D005819:Genetic Markers; D020022:Genetic Predisposition to Disease; D040941:Heredity; D006657:Histones / Q000378:metabolism; D006801:Humans; D008103:Liver Cirrhosis / Q000175:diagnosis / Q000235:genetics* / Q000378:metabolism / Q000628:therapy*; D010375:Pedigree; D010641:Phenotype; D011379:Prognosis; D011499:Protein Processing, Post-Translational; D022661:RNA, Untranslated / Q000235:genetics / Q000378:metabolism; D012307:Risk Factors
chemical_list: D005819:Genetic Markers; D006657:Histones; D022661:RNA, Untranslated
keywords: DNA methylation; Epigenetics; Epimutations; Hepatic stellate cells; Histone modification; Inheritance; Liver cirrhosis; Long noncoding RNA; MicroRNA; Transcription regulation